15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)

被引：0
|
作者：
Aminian, Ali [1 ]
ALJabri, Abdullah [1 ]
Wang, Sarah [1 ]
Bena, James [1 ]
Allende, Daniela [1 ]
Rosen, Hana [1 ]
Wilson, Rickesha [1 ]
Milinovich, Alex [1 ]
Loomba, Rohit [2 ]
Sanyal, Arun J. [3 ]
Alkhouri, Naim [4 ]
Wakim-Fleming, Jamile [1 ]
Dasarathy, Srinivasan [1 ]
McCullough, Arthur [1 ]
Nissen, Steven [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Univ Calif San Diego, La Jolla, CA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Arizona Liver Hlth, Phoenix, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-125
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [31] CLINICALLY SIGNIFICANT PORTAL HYPERTENSION BY NON-INVASIVE TESTS IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) WITH OBESITY AND OVERWEIGHT
    Vezozzo, Denise
    Reinoso, Gleicy
    Rocha, Betania
    Ziteli, Patricia
    Rocha, Sofia
    Stefano, Jose Tadeu
    Franca, Joao Italo Dias
    Carrilho, Flair Jose
    Oliveira, Claudia
    HEPATOLOGY, 2024, 80 : S638 - S638
  • [32] SEPSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES AND HIGHER MORTALITY?
    Kim, Do Han
    Ko, Donghyun
    Argueta, Pedro Palacios
    Kroner, Paul T.
    Lukens, Frank
    Corral, Juan E.
    GASTROENTEROLOGY, 2024, 166 (05) : S1661 - S1662
  • [33] Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective
    Younossi, Zobair M.
    Razavi, Homie
    Sherman, Michael
    Allen, Alina M.
    Anstee, Quentin M.
    Cusi, Kenneth
    Friedman, Scott L.
    Lawitz, Eric
    Lazarus, Jeffrey V.
    Schuppan, Detlef
    Romero-Gomez, Manuel
    Schattenberg, Joern M.
    Vos, Miriam B.
    Wong, Vincent Wai-Sun
    Ratziu, Vlad
    Hompesch, Marcus
    Sanyal, Arun J.
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [34] Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants
    Sim, Benedix
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Ng, Cheng Han
    Syn, Nicholas
    Nah, Benjamin
    Koh, Benjamin
    Xiao, Jieling
    Ong, Christen
    Koh, Jia Hong
    Tung, Daniel
    Huang, Daniel
    Siddiqui, Mohammad Shadab
    Muthiah, Mark
    Teng, Margaret
    JOURNAL OF HEPATOLOGY, 2024, 80 : S366 - S367
  • [35] Role of Saroglitazar in the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in nondiabetic patients: a prospective observational study
    Kumar, Jata Shankar
    Bhardwaz, Priyanshu
    Kar, Premashis
    JOURNAL OF HEPATOLOGY, 2024, 80 : S609 - S610
  • [36] RECOMMENDATIONS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS ( MASH) DISEASE MANAGEMENT: A MODIFIED DELPHI PANEL
    Watzker, Anna
    Delegge, Mark
    Fernandes, Gail
    Melaragno, Matthew
    Williams, Rhys
    Godinho, Fatima
    Drymaliti, Kyriaki
    Engel, Samuel
    HEPATOLOGY, 2024, 80
  • [37] Non-invasive assessment of liver inflammation in metabolic dysfunction-associated steatohepatitis (MASH) using MRI cytometry
    Jiang, Xiaoyu
    Izzy, Manhal
    Washington, Kay
    Gore, John
    Xu, Junzhong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S595 - S595
  • [38] DIABETES IS A RISK FACTOR FOR SARCOPENIA OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS-DRIVEN CIRRHOSIS
    Sato, Shinya
    Takaya, Hiroaki
    Nishimura, Norihisa
    Kaji, Kosuke
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2024, 80 : S451 - S452
  • [39] Therapeutic implication of human placental extract to prevent liver cirrhosis in rats with metabolic dysfunction-associated steatohepatitis
    Yamagata, Mitsuyoshi
    Tsuchishima, Mutsumi
    Saito, Takashi
    Tsutsumi, Mikihiro
    George, Joseph
    CLINICAL SCIENCE, 2024, 138 (05) : 327 - 349
  • [40] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
12345